SCHEMBL527532

SCHEMBL527532

CCCCC(CC)CC(=Cc1ccc(OC)cc1)C(=O)O.CCCCCCCCOC(=O)C=Cc1ccc(OC)cc1

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.64
LMNA P02545 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.48
APP P05067 5/20 0.47
TAS1R3 Q7RTX0 4/20 0.46
TAS1R1 Q7RTX1 4/20 0.46
HCAR2 Q8TDS4 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
GAA P10253 1/20 0.40
FFAR1 O14842 1/20 0.39
PPARG P37231 1/20 0.39
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39
THRB P10828 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cinoxate SCHEMBL12099393 0.91 TDP1 (0.62) TDP1LMNASMN1; SMN2APPTAS1R3
4-Methoxycinnamic Acid SCHEMBL1548518 0.87 TDP1 (0.60) TDP1LMNATAS1R3TAS1R1THRB
SCHEMBL17627791 0.86 TDP1 (0.56) TDP1TAS1R3TAS1R1THRBATM
SCHEMBL5198950 0.86 TDP1 (0.56) TDP1TAS1R3TAS1R1THRBATM
SCHEMBL126604 0.86 TDP1 (0.56) TDP1TAS1R3TAS1R1THRBATM
Cinnamic Acid SCHEMBL16972733 0.85 TDP1 (0.57) TDP1LMNATAS1R3TAS1R1MEN1
SCHEMBL5677176 0.84 TDP1 (0.50) TDP1TAS1R3TAS1R1FFAR1PPARG
SCHEMBL10437218 0.84 TDP1 (0.45) TDP1LMNASMN1; SMN2TAS1R3TAS1R1
SCHEMBL530371 0.83 TDP1 (0.58) TDP1LMNASMN1; SMN2APPTAS1R3
SCHEMBL7533434 0.82 LMNA (0.52) TDP1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12564549-B2 Cleanser composition SHISEIDO COMPANY, LTD. (JP) 2026-03-03 US disclosed
US-12419822-B2 Compositions based on alkanes and ester(s) with temperature storage stability, use thereof as softening agents and emulsions comprising same TOTALENERGIES ONETECH (FR) 2025-09-23 US disclosed
US-12403077-B2 Use of a new composition for preventing or slowing the appearance of signs of inflammation SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2025-09-02 US disclosed
CN-120152941-A Polysiloxane-coated metal oxide particles, dispersion, composition, cosmetic, and method for producing polysiloxane-coated metal oxide particles 住友大阪水泥股份有限公司 2025-06-13 CN disclosed
CN-119818375-A Transparent oily cleaning agent 株式会社资生堂 2025-04-15 CN disclosed
CN-115485241-B Surface-modified zinc oxide particles, dispersion liquid, and cosmetic 住友大阪水泥股份有限公司 2025-03-25 CN disclosed
CN-115485242-B Surface-modified zinc oxide particles, dispersion liquid, and cosmetic 住友大阪水泥股份有限公司 2025-03-18 CN disclosed
US-12251453-B2 Self-invertible inverse latex comprising polyglycyerol esters, use thereof as a thickening agent, and cosmetic compositions comprising same SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2025-03-18 US disclosed
WO-2024257723-A1 HAIR GROWTH AGENT, FGF-7 PRODUCTION PROMOTING AGENT, AND COMPOSITION FOR SCALP AND HAIR 株式会社メディプラス製薬 2024-12-19 WO disclosed
CN-113164800-B Detergent composition 株式会社资生堂 2024-11-22 CN disclosed
US-20110275712-A1 Oil In Water Emulsion Cosmetic Composition For Skin SHISEIDO COMPANY, LTD. (JP) 2011-11-10 US disclosed
WO-2011136393-A1 ORGANOPOLYSILOXANE AND USE THEREOF AS SURFACTANT, POWDER TREATMENT AGENT, THICKENING AGENT OF OIL -BASED RAW MATERIAL OR GELLING AGENT. GEL AND EMULSION COMPOSITIONS, AS WELL AS, PREPARATIONS FOR EXTERNAL USE AND COSMETICS COMPRISING THE SAME DOW CORNING TORAY CO., LTD. (JP) 2011-11-03 WO disclosed
US-20110213030-A1 External Preparation For Skin SHISEIDO COMPANY, LTD. (JP) 2011-09-01 US disclosed
EP-2292208-A1 EXTERNAL PREPARATION FOR SKIN Shiseido Company, Ltd. (JP) 2011-03-09 EP disclosed
US-20070134176-A1 Color-developing composition, and cosmetic preparation, fragrance product and display article using the same FUKUI HIROSHI 2007-06-14 US disclosed
US-7223799-B2 Color-developing composition and cosmetic, fragrance products and miscellaneous goods for display with the use of the same SHISEIDO RESEARCH CENTER (JP) 2007-05-29 US disclosed
US-20030198614-A1 Hair growers SHISEIDO CO., LTD. (JP) 2003-10-23 US disclosed
US-20030190295-A1 Color-developing composition and cosmetic, fragrance products and miscellaneous goods for display with the use of the same SHISEIDO CO., LTD. (JP) 2003-10-09 US disclosed
EP-1314417-A1 HAIR GROWERS Shiseido Co., Ltd. (JP) 2003-05-28 EP disclosed
EP-1287816-A1 COLOR-DEVELOPING COMPOSITIONS AND COSMETICS, FREGRANCE PRODUCTS AND MISCELLANEOUS GOODS FOR DISPLAY WITH THE USE OF THE SAME Shiseido Co., Ltd. (JP) 2003-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030198614-A1 Hair growers EBP, FGF1, HSD17B7 TDP1 4503/4885LMNA 3775/4885SMN1; SMN2 4653/4885
US-12251453-B2 Self-invertible inverse latex comprising polyglycyerol esters, use thereof as a thickening agent, and cosmetic compositions comprising same UGCG, DAGLA, DAGLB TDP1 2003/4885LMNA 728/4885SMN1; SMN2 3299/4885
US-20110213030-A1 External Preparation For Skin CYP46A1, PROC, CYP24A1 TDP1 4726/4885LMNA 467/4885SMN1; SMN2 3545/4885
US-12564549-B2 Cleanser composition LIPA, SGMS1, SGMS2 TDP1 3460/4885LMNA 1325/4885SMN1; SMN2 3671/4885
US-12419822-B2 Compositions based on alkanes and ester(s) with temperature storage stability, use thereof as softening agents and emulsions comprising same ACOX3, ELOVL3, ACOX1 TDP1 2849/4885LMNA 333/4885SMN1; SMN2 796/4885
US-12403077-B2 Use of a new composition for preventing or slowing the appearance of signs of inflammation C1QBP, MDH2, C9 TDP1 1415/4885LMNA 2963/4885SMN1; SMN2 4162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.